Difficulty: Medium
Average Score: 66%
Practice
Which of the following cholinergic drugs is used in Alzheimer's disease?
Correct answer
C
Rationale
In the context of CNS pharmacology and Alzheimer's disease treatment, the correct answer to the question is C) Tacrine. Tacrine is a centrally acting cholinesterase inhibitor that helps to increase acetylcholine levels in the brain by inhibiting its breakdown. This mechanism of action is crucial in Alzheimer's disease, where a deficiency in acetylcholine is a key factor in cognitive decline.
Option A) Neostigmine and option B) Pyridostigmine are cholinesterase inhibitors as well, but they primarily act peripherally and are used in conditions like myasthenia gravis to improve muscle strength. They do not cross the blood-brain barrier effectively to exert their effects in the central nervous system.
Choosing option D) None of the above is incorrect because Tacrine specifically targets the cognitive symptoms of Alzheimer's disease by increasing acetylcholine levels in the brain. This makes it a more appropriate choice for treating the cognitive decline associated with the condition.
In an educational context, understanding the specific mechanisms of action of different cholinergic drugs is crucial for healthcare professionals when selecting the appropriate therapy for patients with CNS disorders like Alzheimer's disease. By knowing the pharmacological properties of each drug, healthcare providers can make informed decisions to optimize patient outcomes and minimize adverse effects.
Option A) Neostigmine and option B) Pyridostigmine are cholinesterase inhibitors as well, but they primarily act peripherally and are used in conditions like myasthenia gravis to improve muscle strength. They do not cross the blood-brain barrier effectively to exert their effects in the central nervous system.
Choosing option D) None of the above is incorrect because Tacrine specifically targets the cognitive symptoms of Alzheimer's disease by increasing acetylcholine levels in the brain. This makes it a more appropriate choice for treating the cognitive decline associated with the condition.
In an educational context, understanding the specific mechanisms of action of different cholinergic drugs is crucial for healthcare professionals when selecting the appropriate therapy for patients with CNS disorders like Alzheimer's disease. By knowing the pharmacological properties of each drug, healthcare providers can make informed decisions to optimize patient outcomes and minimize adverse effects.